Winmark (NASDAQ:WINA – Get Free Report) announced its earnings results on Wednesday. The specialty retailer reported $3.21 EPS for the quarter, missing the consensus estimate of $3.23 by ($0.02), Zacks reports. Winmark had a negative return on equity of 99.47% and a net margin of 47.09%. The firm had revenue of $27.89 million for the quarter, compared to the consensus estimate of $23.99 million.
Winmark Stock Up 3.4%
Shares of NASDAQ WINA traded up $9.63 during mid-day trading on Wednesday, hitting $292.01. 24,068 shares of the company traded hands, compared to its average volume of 69,608. Winmark has a 1 year low of $280.05 and a 1 year high of $488.83. The business has a 50 day moving average of $319.80 and a two-hundred day moving average of $364.21. The stock has a market capitalization of $1.05 billion, a price-to-earnings ratio of 26.52 and a beta of 0.57.
Analysts Set New Price Targets
Separately, Weiss Ratings cut Winmark from a “hold (c)” rating to a “hold (c-)” rating in a research report on Friday, September 18th. One investment analyst has rated the stock with a Hold rating. Based on data from MarketBeat, the stock has a consensus rating of “Hold”.
Winmark Company Profile
Winmark Corporation is a franchising and equipment-leasing company headquartered in Minneapolis, Minnesota. Through its franchise business, the company supports a portfolio of retail brands focused primarily on the resale of apparel, children’s products, sporting goods and musical instruments.
Winmark’s principal franchise concepts include Plato’s Closet, Once Upon a Child, Play It Again Sports, Style Encore and Music Go Round. These stores acquire and resell gently used merchandise, offering consumers lower-cost alternatives while providing opportunities for individuals to operate locally owned businesses.
Read More
- Five stocks we like better than Winmark
- Don’t Get NVIDIA’s Reflection AI Interest Wrong: Its Moat Could Deepen
- Birkenstock’s Strong Growth Creates a Buying Opportunity
- High Voltage Returns: Navitas Rewires AI Data Centers
- Quantum BioPharma’s Phase 2 Shows Where Biotech Value Actually Gets Built
Receive News & Ratings for Winmark Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Winmark and related companies with MarketBeat.com's FREE daily email newsletter.
